The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review
- PMID: 33627974
- PMCID: PMC7879843
- DOI: 10.4103/jhrs.JHRS_95_18
The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review
Abstract
Background: Polycystic ovary syndrome (PCOS), the major endocrinopathy among reproductive-aged women, is not yet perceived as an important health problem in the world. It affects 4%-20% of women of reproductive age worldwide. The prevalence, diagnosis, etiology, management, clinical practices, psychological issues, and prevention are some of the most confusing aspects associated with PCOS.
Aim: The exact prevalence figures regarding PCOS are limited and unclear. The aim of this review is to summarize comprehensively the current knowledge on the prevalence of PCOS.
Materials and methods: Literature search was performed through PubMed, ScienceDirect, Cochrane Library, and Google Scholar (up to December 2019). All relevant articles published in English language were identified following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.
Results: Our analysis yielded 27 surveys with a pooled mean prevalence of 21.27% using different diagnostic criteria. The proportion of women with PCOS also increased in the last decade.
Conclusion: The current review summarizes and interprets the results of all published prevalence studies and highlights the burden of the syndrome, thereby supporting early identification and prevention of PCOS in order to reverse the persistent upward trend of prevalence.
Keywords: Etiology; diagnostic criteria; polycystic ovary syndrome; prevalence; prevention.
Copyright: © 2020 Journal of Human Reproductive Sciences.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
The association between metabolic syndrome and polycystic ovary syndrome: A systematic review and meta-analysis.Diabetes Metab Syndr. 2019 Mar-Apr;13(2):1481-1489. doi: 10.1016/j.dsx.2019.01.002. Epub 2019 Jan 21. Diabetes Metab Syndr. 2019. PMID: 31336510
-
The prevalence of metabolic syndrome in patients with polycystic ovary syndrome: A systematic review and meta-analysis.Diabetes Metab Syndr. 2019 Jul-Aug;13(4):2747-2753. doi: 10.1016/j.dsx.2019.06.008. Epub 2019 Jun 8. Diabetes Metab Syndr. 2019. PMID: 31405703
-
Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis.Arch Gynecol Obstet. 2024 Jun 26. doi: 10.1007/s00404-024-07607-x. Online ahead of print. Arch Gynecol Obstet. 2024. PMID: 38922413 Review.
-
Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis.Hum Reprod Update. 2018 Nov 1;24(6):694-709. doi: 10.1093/humupd/dmy022. Hum Reprod Update. 2018. PMID: 30059968
-
The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.Hum Reprod. 2016 Dec;31(12):2841-2855. doi: 10.1093/humrep/dew218. Epub 2016 Sep 22. Hum Reprod. 2016. PMID: 27664216 Review.
Cited by
-
Exploring Serum Vitamin D, Sex Hormones, and Lipid Profile Disparities in Women With and Without Polycystic Ovarian Syndrome: A Case-Control Study.Cureus. 2024 May 24;16(5):e60975. doi: 10.7759/cureus.60975. eCollection 2024 May. Cureus. 2024. PMID: 38800769 Free PMC article.
-
Associations between Polycystic Ovary Syndrome (PCOS) and Antibiotic Use: Results from the UAEHFS.Antibiotics (Basel). 2024 Apr 26;13(5):397. doi: 10.3390/antibiotics13050397. Antibiotics (Basel). 2024. PMID: 38786126 Free PMC article.
-
Examining the oleoylethanolamide supplement effects on glycemic status, oxidative stress, inflammation, and anti-mullerian hormone in polycystic ovary syndrome.J Ovarian Res. 2024 May 22;17(1):111. doi: 10.1186/s13048-024-01432-1. J Ovarian Res. 2024. PMID: 38778429 Free PMC article. Clinical Trial.
-
Correlation between anti-mullerian hormone with insulin resistance in polycystic ovarian syndrome: a systematic review and meta-analysis.J Ovarian Res. 2024 May 18;17(1):106. doi: 10.1186/s13048-024-01436-x. J Ovarian Res. 2024. PMID: 38762718 Free PMC article.
-
The Role of Nanomedicine in Benign Gynecologic Disorders.Molecules. 2024 May 1;29(9):2095. doi: 10.3390/molecules29092095. Molecules. 2024. PMID: 38731586 Free PMC article. Review.
References
-
- Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;29:181–91.
-
- Azziz R, Carmina E, Dewailly D. Task force on the phenotype of the polycystic ovary syndrome of the androgen excess and PCOS society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report. Fertil Steril. 2009;91:456–88. - PubMed
-
- Tasali E, Van Cauter E, Ehrmann DA. Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:36–42. - PubMed
-
- Giudice LC. Endometrium in PCOS: Implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab. 2006;20:235–44. - PubMed
-
- Cerda C, Pérez-Ayuso RM, Riquelme A, Soza A, Villaseca P, Sir-Petermann T, et al. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. J Hepatol. 2007;47:412–7. - PubMed
Publication types
LinkOut - more resources
Full Text Sources